Gastroenterology‎ - Nov 29, 2017 Edition

November 29, 2017     Gastroenterology‎     The latest gastroenterology‎ news from News Medical

Changes in microbiome due to antibiotic exposure may increase risk for inflammatory bowel disease   Exposure to antibiotics in mothers may increase risk for inflammatory bowel diseases in their offspring. This is the finding of a study in mice led by researchers from NYU School of Medicine and published Nov. 27 in the journal Nature Microbiology.       Intestinal epithelial stem cells may provide new insights into behavior of cancer cells   The lining of the intestines - the epithelium - does more than absorb nutrients from your lunch. It grows, shrinks, and adjusts the very makeup of its cells in response to whatever you just ate. And understanding that process might just give scientists new insights into the behavior of cancer cells.

Elevated oral pathogens, less bacterial diversity linked to risk of developing precancerous gastric lesions   Elevated pathogen colonization and a lack of bacterial diversity in the mouth were identified in people with precancerous lesions that could precede stomach cancer, finds a new study led by New York University College of Dentistry and New York University School of Medicine.         Portal Hypertensive Gastropathy Signs and Symptoms   Portal hypertensive gastropathy (PHG) is a topic of intense interest to clinicians and endoscopists. PHG refers to a wide range of distinct gastric lesions that appear in the gastric mucous membrane. These lesions may arise as a result of endoscopic variceal blockages, portal hypertension in the lower abdomen, or in patients with gastric cirrhosis.         New cancer drug begins clinical trial in human patients with rare brain tumor   A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma, a rare malignant brain tumor, and glioblastoma multiforme, an aggressive late-stage cancer of the brain.

Study: Cancer patients willing to swap drug efficacy for reduced risk of adverse events   When choosing their preferred treatment, people with chronic lymphocytic leukemia (CLL) place the highest value on medicines that deliver the longest progression-free survival, but are willing to swap some drug efficacy for a reduced risk of serious adverse events according to a study published online in Blood Advances, a Journal of the American Society of Hematology.       Flies could act as autonomous bionic drones to help monitor disease outbreaks   An international research team led by Nanyang Technological University, Singapore have proposed that swarms of flies can be used to help monitor disease outbreaks.

Website: www.news-medical.net Email: info@news-medical.net Telephone: +44 (0)161 457 7150 AZoNetwork UK Ltd. NEO, 4th Floor 9 Charlotte Street, Manchester M1 4ET, UK